image credit: Drazen Zigic / Freepik

Acutus laying off 65% of employees to focus solely on Medtronic heart device deal

November 10, 2023

Acutus developed mapping technology to try to reduce the rate of atrial fibrillation recurrence after patients undergo ablation. The company pitched its non-contact approach to mapping as a better fit for atrial fibrillation and other complex or unstable arrhythmias, but has struggled to translate its belief in the technology into commercial success.

Medtronic acquired Acutus’ left-heart access transseptal crossing business in 2022, paying $50 million upfront and an additional $20 million before the end of the year. The agreement made Medtronic the exclusive distributor of the devices but Acutus remained the manufacturer.

Read More on MedTech Dive